Literature DB >> 20309489

Tricks with clicks: modification of peptidomimetic oligomers via copper-catalyzed azide-alkyne [3 + 2] cycloaddition.

Justin M Holub1, Kent Kirshenbaum.   

Abstract

This tutorial review examines recent developments involving use of Copper-catalyzed Azide-Alkyne [3 + 2] Cycloaddition (CuAAC) reactions in the synthesis, modification, and conformational control of peptidomimetic oligomers. CuAAC reactions have been used to address a variety of objectives including: (i) ligation of peptidomimetic oligomers; (ii) synthesis of ordered "foldamer" architectures; (iii) conjugation of ligands to peptidomimetic scaffolds; and (iv) macrocyclization of peptidomimetics using triazole linkages as conformational constraints. Variations in synthesis protocols, such as the use of different solvent systems, temperatures and copper species are evaluated herein to present a range of variables for the optimization of CuAAC reactions. The overall objectives of these studies are assessed to highlight the widespread applications of the products, which range from bioactive ligands to new materials.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20309489     DOI: 10.1039/b901977b

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  23 in total

1.  Metabolic oligosaccharide engineering with N-Acyl functionalized ManNAc analogs: cytotoxicity, metabolic flux, and glycan-display considerations.

Authors:  Ruben T Almaraz; Udayanath Aich; Hargun S Khanna; Elaine Tan; Rahul Bhattacharya; Shivam Shah; Kevin J Yarema
Journal:  Biotechnol Bioeng       Date:  2011-11-21       Impact factor: 4.530

Review 2.  Transition metal-mediated synthesis of monocyclic aromatic heterocycles.

Authors:  Anton V Gulevich; Alexander S Dudnik; Natalia Chernyak; Vladimir Gevorgyan
Journal:  Chem Rev       Date:  2013-01-10       Impact factor: 60.622

3.  Androgen receptor antagonism by divalent ethisterone conjugates in castrate-resistant prostate cancer cells.

Authors:  Paul M Levine; Eugine Lee; Alex Greenfield; Richard Bonneau; Susan K Logan; Michael J Garabedian; Kent Kirshenbaum
Journal:  ACS Chem Biol       Date:  2012-08-07       Impact factor: 5.100

4.  Organocatalyzed preparation of 1,4,5-trisubstituted-glycosyl-1,2,3-triazole derivatives.

Authors:  Monalisa Kundu; Ishani Bhaumik; Anup Kumar Misra
Journal:  Glycoconj J       Date:  2019-07-05       Impact factor: 2.916

5.  Systematic replacement of amides by 1,4-disubstituted[1,2,3]triazoles in Leu-enkephalin and the impact on the delta opioid receptor activity.

Authors:  Arnaud Proteau-Gagné; Kristina Rochon; Mélissa Roy; Pierre-Julien Albert; Brigitte Guérin; Louis Gendron; Yves L Dory
Journal:  Bioorg Med Chem Lett       Date:  2013-08-12       Impact factor: 2.823

6.  Synthesis of Farnesol Analogues Containing Triazoles in Place of Isoprenes through 'Click Chemistry'

Authors:  Thangaiah Subramanian; Sean Parkin; H Peter Spielmann
Journal:  Synlett       Date:  2012-10       Impact factor: 2.454

7.  Triazole-diindolylmethane conjugates as new antitubercular agents: synthesis, bioevaluation, and molecular docking.

Authors:  Ashruba B Danne; Amit S Choudhari; Shakti Chakraborty; Dhiman Sarkar; Vijay M Khedkar; Bapurao B Shingate
Journal:  Medchemcomm       Date:  2018-04-11       Impact factor: 3.597

Review 8.  Triazole-Modified Nucleic Acids for the Application in Bioorganic and Medicinal Chemistry.

Authors:  Dagmara Baraniak; Jerzy Boryski
Journal:  Biomedicines       Date:  2021-05-31

9.  Peptoids and polyamines going sweet: Modular synthesis of glycosylated peptoids and polyamines using click chemistry.

Authors:  Daniel Fürniss; Timo Mack; Frank Hahn; Sidonie B L Vollrath; Katarzyna Koroniak; Ute Schepers; Stefan Bräse
Journal:  Beilstein J Org Chem       Date:  2013-01-10       Impact factor: 2.883

Review 10.  Macrocyclic drugs and synthetic methodologies toward macrocycles.

Authors:  Xufen Yu; Dianqing Sun
Journal:  Molecules       Date:  2013-05-24       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.